Sir,
Polyomavirus BK (BKV) reactivation can occur in immunosuppressed patients, principally kidney transplantation recipients. Currently, patients at risk for polyomavirus nephropathy (PVN) can be identified amongst other methods, by the presence of cells containing viral inclusion bodies -the so called 'decoy cells' -in the urine or in biopsied tissues. 1 In 2001 Fogazzi et al. described for the first time the identification of decoy cells in the urine sediment of a kidney transplantation recipient using phase-contrast microscopy. 2 More recently, our group reported that decoy cells can also be detected in the urine sediment of kidney transplant patients by the means of bright field microscopy without any special stain. 3 Here we report that this method may also be used to diagnose BKV reactivation in patients with lupus nephritis (LN), a finding that has not yet been described in the literature.
During routine urine sediment analysis of a 17-year-old woman with known history of LN who was on treatment with steroids, 'comet-like' cells were observed. These cells are characterized by an enlarged nucleus, a ground glass appearance, altered chromatin and enlarged nucleoli (Figure 1) , compatible with the classical description of urinary 'decoy cells'. BKV viruria was tested by a commercial qPCR kit (Nanogen, Italy) and a high BKV load was found (556 billion viral copies/ml).
According to Rianthavorn et al., 4 BKV reactivation has a higher prevalence in pediatric patients with systemic lupus erythematosus (SLE) than in the general population. As pediatric patients experience more severe SLE usually requiring a more intense immunosuppressive regimen than adults, the screening for BKV reactivation in this group of patients should be recommended. As BKV reactivation could result in severe clinical complications in patients with SLE, the monitoring of BKV viruria should benefit pediatric patients with chronic and severe SLE who receive intense immunosuppressive therapy.
Since molecular diagnosis techniques are still expensive and not available to the general population in low income countries, the search for decoy cells during routine urinalysis directly in the fresh urine can be a useful tool to help to find the BKV reactivation in these patients.
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